The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions.If you have any queries about the SPCs on our website then please e-mail

Felimazole 1.25 mg Coated tablets for cats

1.25 mg/tablet Coated tablet

Dechra Regulatory B.V.VPA22622/009/003

Main Information

Trade NameFelimazole 1.25 mg Coated tablets for cats
Active SubstancesThiamazole
Strength1.25 mg/tablet
Dosage FormCoated tablet
Licence HolderDechra Regulatory B.V.
Licence NumberVPA22622/009/003

Group Information

ATC CodeQH03BB02 thiamazole
Therapeutic ClassMiscellaneous


Licence Issued13/09/2013
Legal StatusPOM: Prescription Only Medicine as defined in relevant national legislation


Summary of Product CharacteristicsPDF Version
Package LeafletNo document available
Public Assessment ReportPDF Version
« Back